APA (7th ed.) Citation

Kato, Y. (2025). Lenvatinib enhances antitumor immunity of anti-PD-1 antibody. International Journal of Clinical Oncology, 30(4), 666-673. https://doi.org/10.1007/s10147-025-02721-5

Chicago Style (17th ed.) Citation

Kato, Yu. "Lenvatinib Enhances Antitumor Immunity of Anti-PD-1 Antibody." International Journal of Clinical Oncology 30, no. 4 (2025): 666-673. https://doi.org/10.1007/s10147-025-02721-5.

MLA (9th ed.) Citation

Kato, Yu. "Lenvatinib Enhances Antitumor Immunity of Anti-PD-1 Antibody." International Journal of Clinical Oncology, vol. 30, no. 4, 2025, pp. 666-673, https://doi.org/10.1007/s10147-025-02721-5.